BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 03, 2003
 |  BioCentury  |  Strategy

Reimbursing Renagel

Making Genzyme Bigger

Reimbursing Renagel

Because it is an out-patient prescription drug, Renagel sevelamer does not receive Medicare coverage. As a result, reimbursement in part influences who receives it and who does not.

All state Medicaid programs cover Renagel, as do many commercial prescription drug coverage plans. But this doesn't necessarily translate to affordability. "In some cases the co-pay is too high, so the patients can't afford Renagel," said John Butler, senior vice president at GENZ (Cambridge, Mass.) and general manager of the company's renal business.

He estimated that Medicaid or private...

Read the full 450 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >